UnitedHealth Group Incorporated (UNH) is owned by a number of high-value investors. Its largest direct holder is Stephen J. Hemsley Executive Chairman of the Board with 1,300,127 shares. The second-largest direct holder is David S. Wichmann Director and Chief Executive Officer, with 904,169 shares of the company’s stock. In third place with 163,331 shares of UNH is Richard T. Burke Lead Independent Director.
Now turning to institutional ownership of UnitedHealth Group Incorporated (UNH), The Vanguard Group, Inc. is the top holder with 69.0 million shares. The next largest fund holder of this company’s stock is Fidelity Management & Research Co. with 58.0 million shares. In the third-place spot with 45.0 million shares is Capital Research & Management Co. (World Investors).
This company’s stock price was $252.70 at the previous market close, with its latest volume reaching 3729655. Compare that to its average daily volume of 4.21M. Given the fact that this stock has 947.68M shares outstanding, its current market value is sitting at $239.48B. This publicly-traded stock’s 60-month Beta is 0.60. Its Price to Sales ratio is 1.00, its Price to Cash Flow ratio is 17.42, and its Price to Book ratio is 4.52.
UNH stock has achieved a 5-day range of $242.15 to $255.72, with a total performance of +3.35% during that period. Meanwhile, in the past month of trading, this stock has traded in the range of $212.08 to $255.72, generating a +16.28% change during the period. In the past three months, this stock’s price has changed by -0.87%, trading in the range of $212.08 to $257.16.
In the past 5 days, shares of UNH have made a new high 5 times. In the last month, it has made a new high 15 times, and in the past 3 months, it has made a new high 1 time.
Now let’s turn to this public company’s earnings. For the quarter ending 9/29/2019, the earnings per share (EPS) was reported at 3.88. This is a 0.13 difference compared to the consensus estimate of 3.75, amounting to an earnings surprise of 3.50%. In the previous quarter, which ended in 9/29/2019, the consensus estimate was 3.45, making for an earnings surprise of 4.30%. For the quarter ending 3/30/2019, EPS was reported at 3.73, generating a 3.60% earnings surprise.
The Net Income for the most recent full fiscal year, which ended in 12-2018, was $12.0 billion. This is compared to the prior year, where Net Income was $10.0 billion. Meanwhile, this company’s Operating Cash Flow was $15.0 billion for the year, compared to $13.0 billion in 2017. Capital Expenditures for the year were reportedly -$2.0 billion, compared to -$2.0 billion, and Free Cash flow was $13.0 billion compared to the prior year’s $11.0 billion.
UnitedHealth Group Incorporated (UNH) stock currently has a Financial Strength score of 6/10. This is due to a combination of factors, including a Cash to Debt ratio of 0.35, an Equity to Asset ratio of 0.33, a Debt to Equity ratio of 0.78 and a Debt to EBITDA of 2.07. The Interest Coverage of this stock is 10.54, its Piotroski F-Score is 6, its Altman Z-Score is 2.83.
This publicly-traded company’s Profitability and Growth score is 9/10, thanks to a combination of things: an Operating Margin of 7.27, a Net Margin of 5.61, a ROE of 25.23, and a ROC of 230.98.
Shifting focus now to Valuation and Return for UNH, this company’s Price to Tangible Book is 4.15 and its Price to Median PS Value is 1.59. Price to Peter Lynch Fair Value for UNH is now 1.3, and this organization’s Price to Graham Number is 1.84. Meanwhile, its Forward Rate of Return (Yactman) is 18.64.
Certain ratios provide helpful insights into how a stock is performing. The Quick Ratio for UNH is sitting at 0.7, while its Current Ratio is 0.7 and its PEG Ratio is 1.33. This stock’s PB Ratio is 4.15, its PS Ratio is 1.03, its Forward PE Ratio is 15.43, and its PE Ratio without NRI is 18.38. Similarly, its Shiller PE Ratio is 32.41, its Price to Owner Earnings is 20.46, its Price to Free Cash Flow is 19.31 and its Price to Operating Cash Flow is 16.7.